|
KR100591585B1
(ko)
|
1999-08-31 |
2006-06-20 |
깃세이 야쿠힌 고교 가부시키가이샤 |
글루코피라노실옥시피라졸 유도체, 그것을 함유하는 의약조성물 및 그 제조 중간체
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
EP1344780A4
(en)
|
2000-11-30 |
2004-01-28 |
Kissei Pharmaceutical |
GLUCOPYRANOSYLOXYBENZYLBENZOLE DERIVATIVES, MEDICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION
|
|
ATE431830T1
(de)
|
2000-12-28 |
2009-06-15 |
Kissei Pharmaceutical |
Glucopyranosylpyrazolderivate und deren verwendung in arzneimitteln
|
|
MXPA04009229A
(es)
|
2002-03-22 |
2004-11-26 |
Kissei Pharmaceutical |
Cristales derivados de glucopiranosiloxibencil benceno.
|
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
ES2363941T3
(es)
|
2003-03-14 |
2011-08-19 |
Astellas Pharma Inc. |
Derivados de c-glucósido para el tratamiento de diabetes.
|
|
ES2531660T3
(es)
|
2003-08-01 |
2015-03-18 |
Mitsubishi Tanabe Pharma Corporation |
Compuestos novedosos que tienen actividad inhibidora frente a transportador de glucosa dependiente de sodio
|
|
CN103030617A
(zh)
|
2004-03-16 |
2013-04-10 |
贝林格尔.英格海姆国际有限公司 |
吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法
|
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
US7772191B2
(en)
|
2005-05-10 |
2010-08-10 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
|
|
AR059489A1
(es)
|
2006-02-15 |
2008-04-09 |
Boehringer Ingelheim Vetmed |
Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
|
|
US7803778B2
(en)
|
2006-05-23 |
2010-09-28 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
TWI499414B
(zh)
|
2006-09-29 |
2015-09-11 |
Lexicon Pharmaceuticals Inc |
鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法
|
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
|
US7846945B2
(en)
|
2007-03-08 |
2010-12-07 |
Lexicon Pharmaceuticals, Inc. |
Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use
|
|
TW200904405A
(en)
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Pharmaceutical formulations containing an SGLT2 inhibitor
|
|
PT2183263E
(pt)
|
2007-07-26 |
2012-01-11 |
Lexicon Pharmaceuticals Inc |
Processos e compostos úteis na preparação de inibidores do co-transportador 2 de glucose e sódio
|
|
RS56990B1
(sr)
|
2007-09-10 |
2018-05-31 |
Janssen Pharmaceutica Nv |
Postupak za dobijanje jedinjenja koja su korisna kao inhibitori sglt
|
|
TW201011043A
(en)
|
2008-06-20 |
2010-03-16 |
Chugai Pharmaceutical Co Ltd |
Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
|
|
TWI472521B
(zh)
|
2008-07-17 |
2015-02-11 |
Lexicon Pharmaceuticals Inc |
（２ｓ，３ｒ，４ｒ，５ｓ，６ｒ）－２－（４－氯－３－（４－乙氧苄基）苯基）－６－（甲硫）四氫－２ｈ－哌喃－３，４，５－三醇的固體形態與其使用方法
|
|
AU2009286380B2
(en)
|
2008-08-28 |
2011-09-15 |
Pfizer Inc. |
Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
|
|
JP5685550B2
(ja)
*
|
2009-02-13 |
2015-03-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｓｇｌｔ２阻害剤、ｄｐｐ−ｉｖ阻害剤、更に必要により抗糖尿病薬を含む医薬組成物及びその使用
|
|
DK2396005T3
(da)
*
|
2009-02-13 |
2026-02-09 |
Boehringer Ingelheim Int |
Sglt2 hæmmer til at forbedre glykæmisk kontrol
|
|
US20110014284A1
(en)
|
2009-02-13 |
2011-01-20 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
|
|
SG2014012553A
(en)
|
2009-04-16 |
2014-05-29 |
Taisho Pharmaceutical Co Ltd |
Pharmaceutical compositions
|
|
PT2486029E
(pt)
|
2009-09-30 |
2015-10-14 |
Boehringer Ingelheim Int |
Processos para a preparação de derivados de benzil-benzeno substituídos com glucopiranosilo
|
|
EA020798B1
(ru)
|
2009-09-30 |
2015-01-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
СПОСОБ ПОЛУЧЕНИЯ КРИСТАЛЛИЧЕСКОЙ ФОРМЫ 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА
|
|
WO2014123749A1
(en)
*
|
2013-01-30 |
2014-08-14 |
Board Of Regents Of The University Of Nebraska |
Compositions and methods for treating complications associated with diabetes
|
|
EA201791258A1
(ru)
*
|
2015-01-09 |
2017-12-29 |
Джилид Аполло, Ллс |
Комбинированная терапия с применением ингибитора ацетил-коа-карбоксилазы (acc) для лечения неалкогольной жировой болезни печени
|
|
EP3455216B1
(en)
|
2016-05-12 |
2020-11-04 |
Boehringer Ingelheim International GmbH |
Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors
|